Vivani Medical (Nasdaq:VANI) subsidiary Cortigent announced the results of a study evaluating its Orion visual cortical ...

About 30 million people around the world have grown legally blind due to retinal diseases. The EPI-RET project has sought for a technical solution for the past twelve years to help these patients.

Elon Musk's Neuralink prepares Blindsight implant human trials by 2026, aiming to restore vision for the blind with FDA Breakthrough Device Designation.

The firm has announced its readiness to implant a new device, Blindsight, into a human patient. The move comes as part of the company's broader mission to develop brain-computer interfaces (BCIs).

An international research team led by Prof. Dr. Sedat Nizamoğlu from the Department of Electrical and Electronics Engineering ...

Elon Musk says Neuralink is ready for its first human implant aimed at restoring vision in blind people, with future versions ...

Retinitis pigmentosa and age-related macular degeneration are two significant causes of severe visual dysfunction. In both, the retinal photoreceptors degenerate, preventing successful conversion of ...

Neural computation scientists have created a software system that is hoped to improve the function of retinal implants significantly: With the aid of the software, the visual prosthesis "learns" to ...

The Intracortical Visual Prosthesis (ICVP), an implant that bypasses the retina and optic nerves to connect directly to the brain's visual cortex, has been successfully surgically implanted in the ...

SYLMAR, Calif.--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ:EYES) ("Second Sight" or "the Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are ...

The Intracortical Visual Prosthesis (ICVP), an implant that bypasses the retina and optic nerves to connect directly to the brain’s visual cortex, has been successfully surgically implanted in the ...

A retinal prosthesis system can safely, effectively, and reliably restore enough visual function to patients with late-stage retinitis pigmentosa to improve object detection and overall well-being, ...